Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-Rüdiger Burmester

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Arthritis Research & Therapy|October 19, 2017
Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonographyMarisa Christin Beck, Anne-Marie Glimm, Sarah Ohrndorf, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating studyCornelia M Spies, Paula Hoff, Jeannine Mazuch, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Annals of the Rheumatic Diseases|November 3, 2012
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosusThomas Rose, Andreas Grützkau, Heike Hirseland, et al.
Arthritis Research & Therapy|January 30, 2014
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesisAngela Kill, Christoph Tabeling, Reinmar Undeutsch, et al.
Arthritis and Rheumatism|April 3, 2008
Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosusRobert Biesen, Cemal Demir, Fidan Barkhudarova, et al.
Annals of the Rheumatic Diseases|September 2, 2015
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusCaroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, et al.
Annals of the Rheumatic Diseases|October 27, 2009
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor functionVelia Gerl, Alexandra Lischka, Daniel Panne, et al.
American Journal of Human Genetics|April 28, 2006
Cis- and trans-acting gene regulation is associated with osteoarthritisSandra Mahr, Gerd-Rüdiger Burmester, Dietmar Hilke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxiaTimo Gaber, Saskia Schellmann, Kerem B Erekul, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Arthritis Research & Therapy|October 19, 2017
Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonographyMarisa Christin Beck, Anne-Marie Glimm, Sarah Ohrndorf, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating studyCornelia M Spies, Paula Hoff, Jeannine Mazuch, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Annals of the Rheumatic Diseases|November 3, 2012
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosusThomas Rose, Andreas Grützkau, Heike Hirseland, et al.
Arthritis Research & Therapy|January 30, 2014
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesisAngela Kill, Christoph Tabeling, Reinmar Undeutsch, et al.
Arthritis and Rheumatism|April 3, 2008
Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosusRobert Biesen, Cemal Demir, Fidan Barkhudarova, et al.
Annals of the Rheumatic Diseases|September 2, 2015
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusCaroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, et al.
Annals of the Rheumatic Diseases|October 27, 2009
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor functionVelia Gerl, Alexandra Lischka, Daniel Panne, et al.
American Journal of Human Genetics|April 28, 2006
Cis- and trans-acting gene regulation is associated with osteoarthritisSandra Mahr, Gerd-Rüdiger Burmester, Dietmar Hilke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxiaTimo Gaber, Saskia Schellmann, Kerem B Erekul, et al.
Pageof 18